| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |